Grindeks
Latvia · Pharma & Healthcare
LeaveRussia detail: Continue Operations
JSC Grindeks is an internationally operating Latvian pharmaceutical company with headquarters in Riga, Latvia. Its portfolio consists of original products, generics, and active pharmaceutical ingredients. It mostly focuses on cardiovascular, central nervous system, anti-cancer and diabetes medicines.
Decision trail
Decision date 28/08/2023 · Reference ↗
The pharma giant Grindeks exporting to Belarus, whereas its subsidiary Kalceks exports to Russia. Grindeks' turnover in 2022 was EUR 258 million, of which EUR 70.6 in Russia.
Local stats (LeaveRussia)
Staff(RF), 2021
89
Revenue(RF), mln.USD
56
Assets(RF), mln.USD
46
Taxes(RF), mln.USD
1
Status history since 2022
- 03/08/2026 — operating · Imported from KSE LeaveRussia
Exposure profile
Full exposure profile is a Professional feature
Energy, transport and commodity exposure, supplier/customer links in the region and sanctioned-party proximity.
Upgrade to Professional